The Food and Drug Administration is working to introduce new requirements for the regulation and monitoring of nutritional supplements. In a statement, the FDA stated that it wanted to protect Americans from the potential dangers of products that do not meet the agency's standards, especially those that "are loaded with drug ingredients that are not on their labels, misleading information and others Risks "(1
"I realize that dietary supplements play an important role in our lives when we strive to stay healthy," said Scott Gottlieb, M.D., FDA Commissioner, in the FDA's opinion. "The DSHEA presents a number of requirements for the manufacture and labeling of nutritional supplements," he said. "We know that most of the players in this industry act responsibly. However, for bad actors, it is possible to use the halo created by the quality work of legitimate manufacturers to instead sell and sell dangerous products that endanger consumers.
Gottlieb admitted that he had benefited from the use of nutritional supplements and recognized benefits of certain products as part of a comprehensive care plan. The FDA fears that the popularity of supplements will increase the number of potentially dangerous or misleading products. "We want to make sure that supplements contain the ingredients they're labeled for and nothing else," said Gottlieb, "and that these products are consistently manufactured to quality standards."
As it works to develop new policy changes As a dietary supplement, the FDA wants to improve the dialogue with the public and is working to develop a new rapid response tool to educate the public about any concerns about the dietary supplement inform the market to improve and work on product safety ratings Deliver new messages on dietary ingredients (NDI) to help them evaluate a new ingredient before it reaches consumers. The Botanical Safety Consortium, a newly formed group of government officials, scientists and scientists, will help assess the safety of herbal ingredients and other blends dietary supplements and look at innovative toxicological tools, alternatives to animal testing and further improvements in the industry.
Calling on some companies with questionable ingredients, the FDA has recently sent 12 warning letters and five online guidance letters to companies. These companies may have launched supplements with unproven claims for the prevention, treatment or cure of Alzheimer's, diabetes, cancer and even opioid addiction. "One of my primary goals is to ensure that we strike the right balance between preserving consumers' access to legitimate supplements while maintaining our solemn commitment to protecting the public from unsafe and unlawful products," said Gottlieb.
Following the agency's recent policy advances, the FDA also appointed the Dietary Supplement Working Group, a team of representatives from all areas of the agency, to oversee organizational structures, processes, procedures and practices in the modernization of their approach to regulation Monitor dietary supplements. after Gottlieb.
"In the coming months, we will provide more detail on the steps we can take to continue pushing our nutritional supplement program to meet those priorities," said Gottlieb. "Our new approach will benefit consumers by balancing new policies to drive innovation and efficiency in the dietary supplement market and step up efforts to protect the public from potential security risks."